Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Personalized Medicine|May 27, 2023
Accuracy of Conventional and Digital Impressions for Full-Arch Implant-Supported Prostheses: An In Vitro StudyNoemie Drancourt, Chantal Auduc, Aymeric Mouget, et al.
Plos One|July 30, 2011
Effect of dental status on changes in mastication in patients with obesity following bariatric surgeryAnne Espérance Godlewski, Jean Luc Veyrune, Emmanuel Nicolas, et al.
European Cytokine Network|April 6, 2005
Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factorsMichel Jourdan, Karène Mahtouk, Jean-Luc Veyrune, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 8, 2009
Increased plasma-immune cytokines throughout the high-dose melphalan-induced lymphodepletion in patients with multiple myeloma: a window for adoptive immunotherapyMaud Condomines, Jean-Luc Veyrune, Marion Larroque, et al.
Stem Cell Research & Therapy|May 23, 2020
Correction to: Characterization of immortalized human islet stromal cells reveals a MSC-like profile with pancreatic featuresOrianne Villard, Mathieu Armanet, Guilhem Couderc, et al.
Stem Cell Research & Therapy|April 19, 2020
Characterization of immortalized human islet stromal cells reveals a MSC-like profile with pancreatic featuresOrianne Villard, Mathieu Armanet, Guilhem Couderc, et al.
Oncotarget|November 17, 2012
Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?Anouk Caraux, Laure Vincent, Salahedine Bouhya, et al.
Cancer Research|January 26, 2022
Targeting Cellular Iron Homeostasis with Ironomycin in Diffuse Large B-cell LymphomaJulie Devin, Tatiana Cañeque, Yea-Lih Lin, et al.
Journal of Clinical Medicine|July 16, 2020
A Retrospective Comparison of DLI and gDLI for Post-Transplant TreatmentSylvain Lamure, Franciane Paul, Anne-Laure Gagez, et al.
British Journal of Cancer|March 4, 2018
DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cellsAngelique Bruyer, Ken Maes, Laurie Herviou, et al.
Pageof 4